Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1385127.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report our experience in the follow-up of 63 patients with advanced prostate adenocarcinoma. We used prostate-specific antigen and prostatic acid phosphatase in 27 patients; in 36 patients we evaluated osteocalcin and bone isoenzyme of alkaline phosphatase, two markers of bone metabolism which seem to be good markers in the follow-up of patients with bone metastases.
Medical subject headings
- Acid Phosphatase
- Adenocarcinoma
- Alkaline Phosphatase
- Biomarkers, Tumor
- Isoenzymes
- Osteocalcin
- Prostate-Specific Antigen
- Prostatic Neoplasms